ADICET BIO INC (ACET) Forecast, Price Target & Analyst Ratings
NASDAQ:ACET • US0070022076
7.57 USD
+0.55 (+7.83%)
Last: Mar 4, 2026, 08:07 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ADICET BIO INC (ACET).
Forecast Snapshot
Consensus Price Target
$62.73
+ 728.67% Upside
Next Earnings Forecast
Release DateMay 4, 2026
PeriodQ4 / 2025
EPS Estimate-$2.86
Revenue Estimate
ChartMill Buy Consensus
86.15%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$62.73
Upside
+ 728.67%
From current price of $7.57 to mean target of $62.73, Based on 13 analyst forecasts
Low
$18.18
Median
$38.25
High
$134.40
Price Target Revisions
1 Month
-38.25%
3 Months
709.21%
Price Target Summary
13 analysts have analysed ACET and the average price target is 62.73 USD. This implies a price increase of 728.67% is expected in the next year compared to the current price of 7.57.
The average price target has been revised upward by 709.21% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
86.15%
ACET was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about ACET.
In the previous month the buy percentage consensus was at a similar level.
ACET was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-11-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-08 | Guggenheim | Maintains | Buy -> Buy |
| 2025-09-19 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-03-21 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-03-07 | Citizens Capital Markets | Reiterate | Market Perform -> Market Perform |
| 2025-03-07 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-02-27 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-02-06 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2025-02-05 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-12-19 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-10-16 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-09-30 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-09-20 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-09-19 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-09-11 | Jones Trading | Maintains | Buy -> Buy |
| 2024-09-11 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-09-11 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-08-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 4, 2026
PeriodQ4 / 2025
EPS Estimate-$2.86
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q-793.14%
Number of Analysts9
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
-1,500.00%
Next Earnings Summary
ACET is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -2.86 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 17.9M | 9.73M -45.64% | 24.99M 156.83% | 637.5K -100.00% | 52.143M | 93.98M 80.24% | 226.07M 140.55% | 203.6M -9.94% | 373.4M 83.40% | 553.66M 48.28% | |||||
| EBITDA YoY % growth | -37.96M 55.51% | -58.69M -54.61% | -69.97M -19.22% | -159.12M -80.76% | -156.06M 3.91% | -176.46M -45.20% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -39.19M 54.14% | -60.23M -53.69% | -72.55M -20.45% | -153.056M -82.74% | -133.443M 3.45% | -119.268M 6.82% | -125.473M -5.20% | -130.815M -4.26% | -86.865M 33.60% | -61.363M 29.36% | 32.499M 152.96% | -10.254M -131.55% | 127.47M 1,343.12% | 273.45M 114.52% | |
| Operating Margin | -218.94% | -619.01% | -290.32% | -24,008.71% | N/A | N/A | N/A | N/A | -166.59% | -65.29% | 14.38% | -5.04% | 34.14% | 49.39% | |
| EPS YoY % growth | -5.68 65.62% | -2.07 63.56% | -1.71 17.39% | -54.16 -94.15% | -22.53 59.64% | -16.65 -1,142.65% | -12.10 27.34% | -11.62 3.94% | -0.28 97.59% | 1.39 596.98% | 10.18 630.23% | -11.59 -213.83% | -3.43 70.42% | 5.22 252.38% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.86 -793.14% | -3.00 39.59% | -3.04 44.13% | -3.09 33.35% | -0.18 93.76% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -27.091M 11.88% | -30.443M -1.87% | -31.832M 0.53% | -32.654M -12.34% | -33.592M -24.00% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-105.46%
EPS Next 5 Year
24.91%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ADICET BIO INC / ACET Forecast FAQ
What is the price target for ACET stock?
13 analysts have analysed ACET and the average price target is 62.73 USD. This implies a price increase of 728.67% is expected in the next year compared to the current price of 7.57.
Can you provide the upcoming earnings date for ADICET BIO INC?
ADICET BIO INC (ACET) will report earnings on 2026-05-04.
Can you provide the consensus estimates for ADICET BIO INC next earnings?
The consensus EPS estimate for the next earnings of ADICET BIO INC (ACET) is -2.86 USD and the consensus revenue estimate is 0 USD.